CompariSkin Featured in:

There’s an app for that?

DW dives into dermatology apps for patient monitoring, point-of-care, teledermatology, reference material, and practice efficiency. … of functionality. This trend has potential for patient health benefits, says Gary Lichten, MD, dermatologist… that the patient be able to track their own lesions,” says Dr. Lichten, who first began work on the app…

View the complete interview at

CompariSkin Introduces Skin Monitoring App

Dermatologist-designed CompariSkin enables accurate mole mapping technology 

Akron, OH. – February 21, 2017 – CompariSkinTM, a digital map for healthier skin designed by expert dermatologist, announces the launch of CompariSkin 2.2, available for free download in the Apple App Store.

The CompariSkin app, formerly recognized as MoleMapper Plus, was designed to allow users to track changes in their skin with 3D imaging, compare and overlay. With CompariSkin, the 3D model captures accurate images of skin, including moles, birthmarks, jaundice and rashes, to create a database of transformations. Users can create a baseline map, recording images of different regions of the body, and compare skin maps by simply selecting images. Results can be charted, including reports for follow-ups and biopsies, and include a text field to record notes from routine doctors visits. With CompariSkin, users have a portable record of their skin history to share with their physician to identify early warning signs – detecting skin cancer earlier and reducing the risk for unnecessary biopsies.

“One in five Americans will develop skin cancer and the growth rate of melanoma, the deadliest of skin cancers, continues to increase,” said Dr. Gary Lichten, industry-leading dermatologist and founder of CompariSkin. “With CompariSkin, users are able to monitor and track changes in there skin, as well as provide them with records to review with their doctor. Having a photograph as a record enables doctors to better determine a course of action and objectively judge change within skin zones and close-ups.”

Dr. Gary Lichten, founder of CompariSkin, is board certified in Dermatology and Internal Medicine and practices adult and pediatric dermatology, with an emphasis on diagnosis of skin cancer and skin disease, in northern Ohio. A graduate of the Ohio State University College of Medicine, Dr. Lichten is a member of the American Academy of Dermatology, Ohio State Medical Association, Ohio Dermatological Association and Cleveland Dermatological Society. As a practicing dermatologist, Dr. Gary Lichten understands the demand for a reliable skin mapping and mole mapping application, which led to the development of CompariSkin.

DermMapper Plus LLC – 4125 Medina Rd, Akron, OH 44333 – 

For more information on CompariSkin, please visit Follow CompariSkin on Facebook and Twitter for the latest news.

About CompariSkinTM 

Designed by experienced dermatologist Dr. Gary Lichten, CompariSkinTM is a digital map for healthier skin. CompariSkin is an innovative skin mapping and mole mapping application allowing users to track changes in their skin and record their personal data – all within CompariSkin. The user-friendly app includes a 3D model to capture clear images and track and compare changes over time. By tracking the appearance of moles, users can protect themselves against skin cancer and other skin-related illnesses. The CompariSkin app is available for download in the Apple App Store

Media Contact: 

Morgan Roush
Public Relations Consultant
Tel: 419-631-8052

CompariSkin featured on:

The following editorial was featured in Practice Update, and describes the monitoring and evolution of Spitz Nevi:

Evolution of Spitz Nevi:

Nazan Emiroglu , M.D.,* Pelin Yıldız, M.D.,† Dilek Biyik Ozkaya, M.D.,* Anıl Gulsel

Bahalı, M.D.,* Ozlem Su, M.D.,* and Nahide Onsun, M.D.* Pediatric Dermatology 1–8, 2017

Gary D. Lichten, M.D.

Seventy Spitz nevi were studied: 43 initially excised, 26 involuted, and 6 remained.

Twenty-seven were followed clinically and with dermoscopy images. The dermoscopy pattern, most frequently observed, was globular, followed by starburst. The age group was younger with the Spitz nevi that involuted: age14.3 (range 4.6 years), contrasted with mean age of the stable group was 19.0 (range 4.2 years). The range for involution of lesions was 21-27 months.

Although the number of cases were limited, the practice of following Spitz nevi in younger children with clinical and with dermoscopy images is laudable.  When viewing a suspicious pigmented lesion, because of the fear of missing a melanoma, we choose surgical removal as the first option. When given a choice, patients and parents frequently opt to be followed with photographs, and thus avoid a procedure and scar. With typical Spitz nevi in children as well as atypical nevi, I frequently follow nevi with dermoscopy images.

Although the authors followed Spitz nevi every 6 months, for atypical nevi, I use short-term, three month, monitoring.  Patients are engaged with taking and comparing images monthly with an application, with instructions to return immediately for excision if any change is noted.  Flat, atypical nevi, excluding those with any melanoma specific features ( atypical or negative network, irregular globes or streaks, blue-white colors, regression structures) are photographed with dermoscopy initially and again at 3 months.  I recommend the free application, CompariSkinFree,, which enables patients to take consistent images and compare for changes with side-by-side and overlaid images within one minute.

Sequential dermoscopy images tell a story of change, which can be reassuring to the patient and parents for Spitz nevi, as well as atypical pigmented nevi.

1. Dr. Lichten developed  CompariSkinFree

Selfies that matter

Selfies matter.

We take many selfies, but have you considered snapping a few pictures of your skin and moles to keep as a reference?

Taking pictures of your skin provides valuable information: if a mole is changing, a biopsy is frequently indicated. If not, and the appearance is not convincing for malignancy, why biopsy?

Recently, I saw a patient for whom I suggested monitoring her moles with  photographs. Upon returning after three months, the patient stated assuredly that the mole on her shoulder had not changed.  When I compared the moles with side-by-side pictures, the mole had changed and the biopsy revealed an evolving melanoma that required additional surgery to ensure complete removal.

I welcome pictures from patients. The photo not only provides information on how it looked, but also enables me to deduce whether change has occurred. One photo affects my decision-making process.

Additionally this month, I saw a young mother who had an infection on her face. She visited a stat-care facility on the day before and received antibiotics. When I looked at her pictures, I knew that her therapy was working and she did not require any change in therapy. That change would have been antibiotics administered at the hospital for her cellulitis, a serious skin infection.

I have made these decisions with the use of one photograph:

  1. Obtaining a biopsy of a changing mole: most proven to be cancerous or premalignant
  2. Avoiding a biopsy
  3. Confirming the site of a previous biopsy before surgery
  4.  Altering treatment
  5.  Avoiding blood tests
  6. Determining the efficacy of procedures and skincare regimens


Having a photograph as a record enables you and your doctor with the decision making process.  Especially today, with the frustrations of navigating the healthcare system, anything that you can do to take charge, advocate for your health, and be empowered, can affect outcome. Having a record of your moles in an organized way helps alleviate some of the frustrations. Understanding the needs of the patient, along with the importance of monitoring skin and moles for change, motivated the development of the application CompariSkin, with its’ innovative software.

CompariSkin was created to help patients track their skin and moles for change, or mole mapping.

Research has proven that mole mapping detects skin cancer earlier and reduces unnecessary biopsies.

One in five Americans will develop skin cancer (4,000,000 per year). The growth rate of melanoma, the deadliest of skin cancers, continues to increase. One person dies every hour from melanoma (79,800 cases per year).

Although mole mapping is performed at most major teaching health centers, the procedure is rarely performed in the doctor’s office. Several estimates state that than fewer than 5% of dermatologists perform mole mapping.  Today’s technology assists you with mapping your skin. The objective is to detect changes sooner, which could indicate skin cancer, as well as to minimize unnecessary biopsies, surgeries, scars, and expense. Furthermore, instead of wondering whether a mole has changed, it can be reassuring to look at a photograph.

Did you know that radiologists compare prior xrays and universally comment on any change in their report? Why is this practice of comparing pictures not being performed by more physicians? I am disappointed that our electronic medical records  lack organization  when viewing and comparing photographs.

The application is unique and the most thorough application because you use reproducible 3D imaging with side-by-side, and overlaid images. These features provide consistency  to objectively judge change. The program allows you to compare, both skin zones and close-ups, in the most thorough, organized way.

Who should be mapped?

Have you had a biopsy that was unnecessary?

Do you have a birthmark or congenital nevi, personal or family history of melanoma or atypical or dysplastic moles? Do you have greater than 20 moles on a leg or 11 on the right arm or over 50 total, history of tanning beds, two or more sunburns, fair skin, green or blue eyes or blond or red hair? Are you immunosuppressed? Have you had skin cancer? With a history of one basal cell or squamous cell skin cancer, there is a 45% chance for another.

Do you wonder whether your procedures and skincare are delivering expected results? The answer is clear with viewing side-by-side, before and after pictures.

The signs of skin cancer can be a new mole, a bleeding spot, or an itching growth. Most melanomas develop new, not from a preexisting mole, after the age forty.

The ABCDEs of melanoma:

A (symmetry)

B (border)

C (color variegated)

D (diameter greater than a Pencil eraser)

E (evolution)

E, for change, is the most important sign. That is why monitoring your moles is so important: any detected change warrants a visit to your doctor to determine whether skin cancer is developing and whether to surgically to remove the growth. If your doctor finds a suspicious mole, he or she may suggest short term monitoring of one body area for three to four months. If you detect any change, prompt and complete removal of the mole is indicated.

Simply snapping a picture of your skin enables you to tell a story of change and to provide information that can be critical for the decision-making process. Furthermore, the app assists with record keeping by enabling you to see reports and the location of any surgery.

While no application can replace a visit to your doctor, taking charge of your health can affect the outcome.

Advocate for your health.

Download the most thorough and innovative skin application, CompariSkin, today, and start taking selfies that really matter.


Gary Lichten, M.D.